STUDY OBJECTIVES: To interact with the robotic Phoenix Mars Lander (PML) spacecraft, mission personnel were required to work on a Mars day (24.65 h) for 78 days. This alien schedule presents a challenge to Earth-bound circadian physiology and a potential risk to workplace performance and safety. We evaluated the acceptability, feasibility, and effectiveness of a fatigue management program to facilitate synchronization with the Mars day and alleviate circadian misalignment, sleep loss, and fatigue. DESIGN: Operational field study. SETTING: PML Science Operations Center. PARTICIPANTS: Scientific and technical personnel supporting PML mission. INTERVENTIONS: Sleep and fatigue education was offered to all support personnel. A subset (n = 19) were offered a short-wavelength (blue) light panel to aid alertness and mitigate/reduce circadian desynchrony. They were assessed using a daily sleep/work diary, continuous wrist actigraphy, and regular performance tests. Subjects also completed 48-h urine collections biweekly for assessment of the circadian 6-sulphatoxymelatonin rhythm. MEASUREMENTS AND RESULTS: Most participants (87%) exhibited a circadian period consistent with adaptation to a Mars day. When synchronized, main sleep duration was 5.98 ± 0.94 h, but fell to 4.91 ± 1.22 h when misaligned (P < 0.001). Self-reported levels of fatigue and sleepiness also significantly increased when work was scheduled at an inappropriate circadian phase (P < 0.001). Prolonged wakefulness (≥ 21 h) was associated with a decline in performance and alertness (P < 0.03 and P < 0.0001, respectively). CONCLUSIONS: The ability of the participants to adapt successfully to the Mars day suggests that future missions should utilize a similar circadian rhythm and fatigue management program to reduce the risk of sleepiness-related errors that jeopardize personnel safety and health during critical missions.
STUDY OBJECTIVES: To interact with the robotic Phoenix Mars Lander (PML) spacecraft, mission personnel were required to work on a Mars day (24.65 h) for 78 days. This alien schedule presents a challenge to Earth-bound circadian physiology and a potential risk to workplace performance and safety. We evaluated the acceptability, feasibility, and effectiveness of a fatigue management program to facilitate synchronization with the Mars day and alleviate circadian misalignment, sleep loss, and fatigue. DESIGN: Operational field study. SETTING: PML Science Operations Center. PARTICIPANTS: Scientific and technical personnel supporting PML mission. INTERVENTIONS: Sleep and fatigue education was offered to all support personnel. A subset (n = 19) were offered a short-wavelength (blue) light panel to aid alertness and mitigate/reduce circadian desynchrony. They were assessed using a daily sleep/work diary, continuous wrist actigraphy, and regular performance tests. Subjects also completed 48-h urine collections biweekly for assessment of the circadian 6-sulphatoxymelatonin rhythm. MEASUREMENTS AND RESULTS: Most participants (87%) exhibited a circadian period consistent with adaptation to a Mars day. When synchronized, main sleep duration was 5.98 ± 0.94 h, but fell to 4.91 ± 1.22 h when misaligned (P < 0.001). Self-reported levels of fatigue and sleepiness also significantly increased when work was scheduled at an inappropriate circadian phase (P < 0.001). Prolonged wakefulness (≥ 21 h) was associated with a decline in performance and alertness (P < 0.03 and P < 0.0001, respectively). CONCLUSIONS: The ability of the participants to adapt successfully to the Mars day suggests that future missions should utilize a similar circadian rhythm and fatigue management program to reduce the risk of sleepiness-related errors that jeopardize personnel safety and health during critical missions.
Authors: G C Brainard; J P Hanifin; M D Rollag; J Greeson; B Byrne; G Glickman; E Gerner; B Sanford Journal: J Clin Endocrinol Metab Date: 2001-01 Impact factor: 5.958
Authors: Jeanne F Duffy; Sean W Cain; Anne-Marie Chang; Andrew J K Phillips; Mirjam Y Münch; Claude Gronfier; James K Wyatt; Derk-Jan Dijk; Kenneth P Wright; Charles A Czeisler Journal: Proc Natl Acad Sci U S A Date: 2011-05-02 Impact factor: 11.205
Authors: Christian Cajochen; Mirjam Münch; Szymon Kobialka; Kurt Kräuchi; Roland Steiner; Peter Oelhafen; Selim Orgül; Anna Wirz-Justice Journal: J Clin Endocrinol Metab Date: 2004-12-07 Impact factor: 5.958
Authors: Mathias Basner; David F Dinges; Daniel Mollicone; Adrian Ecker; Christopher W Jones; Eric C Hyder; Adrian Di Antonio; Igor Savelev; Kevin Kan; Namni Goel; Boris V Morukov; Jeffrey P Sutton Journal: Proc Natl Acad Sci U S A Date: 2013-01-07 Impact factor: 11.205
Authors: Julia E Stone; Tracey L Sletten; Michelle Magee; Saranea Ganesan; Megan D Mulhall; Allison Collins; Mark Howard; Steven W Lockley; Shantha M W Rajaratnam Journal: J Physiol Date: 2018-04-06 Impact factor: 5.182
Authors: Suzanne Ftouni; Tracey L Sletten; Christian L Nicholas; David J Kennaway; Steven W Lockley; Shantha M W Rajaratnam Journal: J Clin Sleep Med Date: 2015-10-15 Impact factor: 4.062